Implementation of the esophageal string test in clinical practice and research
- PMID: 39522653
- PMCID: PMC12040326
- DOI: 10.1016/j.jaci.2024.11.002
Implementation of the esophageal string test in clinical practice and research
Keywords: Entero-Test; Eosinophilic esophagitis; biomarker; eosinophil; esophageal string test; minimally invasive.
Conflict of interest statement
Disclosure statement Supported in part by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant K23AI158813 [to B.L.W.]). Disclosure of potential conflict of interest: S. Schroeder reports being a consultant for Regeneron, Takeda, and EvoEndo and received research funding from Regeneron, Celgene, and AstraZeneca. B. L. Wright reports in-kind support from Regeneron in the form of study drug (dupilumab and placebo) for a clinical trial of milk oral immunotherapy. The remaining author declares that she has no relevant conflicts of interest.
References
-
- Entero-Test 510(k) Summary.] Available from https://www.accessdata.fda.gov/cdrh_docs/pdf/k983119.pdf.
-
- Quinn LA, Andrews R, Bauer M, Nguyen N. Utilization and impact of esophageal string testing in children with eosinophilic esophagitis: A 1 year experience. J Pediatr Gastroenterol Nutr 2024. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
